| Application no. and date | 18202878.7 (espacenet) (Federated) (European Patent Register), 20181026 | | Patent/reg. no. and date | DK/EP 3643704, 20201216 | | Publication date | 20200429 | | Priority no. and date | | | EP pub. no. and date |
EP 3643704 20200429 | | Effective date | | | Applicant/owner | hameln pharma gmbh, Inselstraße 1
31787 Hameln, DE | | Applicant ref. no. | V2102-054-DK | | Inventor | VALACHOVIC, Pavol, Hameln rds a.s.
Novomeského 24
902 01 Pezinok, SK,
VARGA, Norbert, Hameln rds a.s.
Komenského 10
900 01 Modra, SK,
KRÃ?LOVÃ?, Janka, Hameln rds a.s.
Novomeského 24
902 01 Pezinok, SK,
SLÃ?ZIK, Lubos, Hameln rds a.s.
Drienková 15
903 01 Senec, SK | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | C07D 211/66 (2006.01) | | Title | NYE MELLEMPRODUKTER TIL FREMSTILLING AF REMIFENTANIL-HYDROCHLORID | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
